Mon, Jul 6, 2020
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Private Equity Strategies

Microcap Monitor: Microcap Activity on The Rise

Monday, October 21, 2013

“We’re seeing more Microcap transactional business than we’ve seen in five years,” David Bukzin, Partner at Marcum tells Private Equity Strategies, in a conversation about Microcap companies. “We’re seeing that activity across all types of transactions, IPOs, SPACs.” Bukzin works with a number of Microcap companies and private equity firms as an accountant for Marcum.

“The markets have gotten to a level where the recovery is starting to trickle down to the smaller companies. Microcap companies are the last to see the upside and the first to feel any backslide.” In our last Microcap Monitor in June, we highlighted DelMar Pharmaceuticals, a company that is working on clinical trials for an orphan disease efractory glioblastoma multiforme (GBM), the most common type of aggressive brain cancer. At that time, life sciences companies as a group were popular with investors and they still are. According to Bukzin, life sciences and technology companies continue to dominate investor interest.

“The Microcap IPO market is coming back,” he says. “These IPOs are companies with under $500 million in market value, and are in these sectors. We’re even hearing rumblings that people are exploring China again. They are looking at what companies want to go public now that a lot of them have gone dark.”

He notes that recent changes in regulation like those to Sarbanes-Oxley have improved the options for Microcap companies. The JOBS Act is also playing a limited role in terms of marketing. “Some of the companies going public now are taking advantage of the JOBS Act, but it really has had little to no effect when it comes to gaining access to capital. What has helped are the changes to Sarbanes-Oxley. Regulations overall, are a balancing act. I think SARBOX was actually helpful in many ways. But the way they’re writing some of these crowdfunding rules, they can open you up to fraud.”

SPAC’s come back

Special-purpose acquisition companies, or SPACs, are starting to become more frequent Bukzin says. Typically SPACs are a type of structure reserved for economies that are booming, but even with anemic growth, they too are coming back along with IPOs. SPAC issuances rely on IPOs to raise capital, and a few successful transactions have emboldened others to jump in.

According to research done by attorneys at Appleby, for Legal Week, “the largest such deal was the $905 million Platform Acquisitions IPO, a special purpose acquisition vehicle incorporated in the BVI and reuniting founders Martin Franklin and Nicolas Berggruen, who were previously behind the 2012 IPO of Burger King using a similar special purpose acquisition company (SPAC) model.”

Bukzin notes that the type of investor for a SPAC transaction is different from a typical IPO investor, “the IPO is more subject to market conditions, in a SPAC the equity has already been raised. With the IPO, you have to get through the SEC before you deal with the market to raise your capital. The SPAC is more institutional in nature, with an IPO you’ll see more retail investors.”

Accounting Changes

Bukzin recently gave a presentation at the JMJ Financial Summit in Las Vegas, Nevada where he highlighted some accounting changes on the horizon that could impact Microcap companies. The Public Company Accounting Oversight Board is set to have a public roundtable next year that could change the auditors’ opinion from pass/fail to something more qualitative. The proposal would add more communication to the auditors report about issues that came up during the audit leading to the opinion.

The Financial Accounting Standards Board (FASB) is also considering some regulatory relief on reporting for development stage companies. Those changes would affect mostly pharmaceutical, biotechnology, and technology companies. Based upon current rules it is difficult for companies to emerge from development stage to an established operating company because current guidance requires meeting the same reporting guidelines as an established operation. The FASB is looking at ways to make these reporting requirements easier for development stage companies.

These rules and a more liquid market environment are bolstering Microcap activity. “We’re seeing clients who are now able to get capital in the last six months, where they haven’t been able to for the past five years,” Bukzin says. “There’s an arbitrage in Microcap because of the lack of liquidity, which creates a lower valuation and private equity firms can take advantage of that.”

Research submitted by Perritt Capital Management following this article goes into those issues in detail. Watch this space.

 
This article was published in Opalesque's Private Equity Strategies our monthly research update on the global private equity landscape including all sectors and market caps.
Private Equity Strategies
Private Equity Strategies
Private Equity Strategies
Private Equity Strategies


Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. New Launches: GP Bullhound raises $141m for its fifth tech fund, LBC Credit Partners V aims to raise $1bn, B Capital shores up $820m in second fund, BayernKapital closes second Bavarian Growth Fund, PGIM Investments launches global corporate ESG bond fund, MSIM launches Paris Agreement-aligned global balanced sustainable fund, Unigestion announces closes for Secondary V and Direct II, Waterton plans $1.25bn fundraise for latest US apartment fund[more]

    GP Bullhound raises $141m for its fifth tech fund From PE News: Technology-focused investment firm GP Bullhound has held the first close of its latest fund with €125m ($141m) of capital commitments. GP Bullhound Fund V is a pan-European venture capital fund targeting primarily l

  2. SWF: UK's Future Fund expansion 'fails to hit the mark', claim business leaders[more]

    From Telegraph: Britain's start-up rescue fund, which has been extended to include UK startups that have moved the headquarters overseas, still "fails to hit the mark" for many early-stage companies, business leaders have warned. The Future Fund, launched in May, provides Government funding of

  3. PE/VC: Disruption from COVID-19 hits ASEAN private equity hard, VCs see much to like in Democrats' $1.5tn Moving Forward Act, US PE firms play the long game as deal-making comes back into focus[more]

    Disruption from COVID-19 hits ASEAN private equity hard Opalesque Industry Update - After a strong 2019, the ASEAN private equity industry has been shaken by the outbreak of the COVID-19 pandemic, reports Preqin. As of September 2019, ASEAN-focused private equity and venture capital asset

  4. Coronavirus crisis: PE industry mulls more realism and longer holding periods[more]

    Laxman Pai, Opalesque Asia: More realism, longer holding periods and an advantage for investors with a long-term focus - these are the main changes that investment managers in the German private equity market expect as a result of the coronavirus crisis. The PE transaction activity is not exp

  5. Multi-strategy hedge funds post double-digit gains, Tiger Global, Coatue score double-digit fund gains in 2020, Lone Pine soars after losses earlier this year, Can Pershing Square's standout year continue?[more]

    Multi-strategy hedge funds post double-digit gains From FT: Large multi-strategy hedge funds have posted double-digit gains for the first half of the year, reversing losses from March, as markets defied the economic downturn brought on by the coronavirus pandemic. Citadel Advisors